Infinity Pharmaceuticals Inc. (INFI) stock gains during pre-market. Let’s see why?
Infinity Pharmaceuticals Inc. (INFI) stock declined by 31.53% at the last close whereas the INFI stock price surges by 49.34% in the pre-market trading session. Infinity is a medical biotechnology firm working on eganelisib (IPI-549) which is an oral immuno-oncology macrophage reprogramming therapy that has been shown to target a basic biologic process of immune […]
